ArticleCureus2025
From Crisis to Cancer: Diabetic Ketoacidosis Unmasking a Malignancy of Unknown Origin.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic ketoacidosis (DKA) is a life-threatening metabolic emergency, but its presentation as the first sign of an occult malignancy is extremely rare, particularly when the primary site is unknown. We report such a rare case of a 37-year-old woman presenting with progressive headache and vomiting. Initial assessment demonstrated DKA with associated electrolyte disturbances, which were managed promptly, and neuroimaging - prompted by concern for raised intracranial pressure - unexpectedly revealed brain metastases. Despite extensive imaging, immunohistochemistry, and multidisciplinary review, no definitive primary site could be identified. She was diagnosed with cancer of unknown primary (CUP) and referred for whole-brain radiotherapy and palliative care. This case illustrates the rare but critical scenario in which an acute metabolic emergency, such as DKA, unmasks an aggressive metastatic malignancy. The incidental detection of brain metastases in the absence of an identifiable primary tumour adds further diagnostic complexity. Early recognition of red flags, timely imaging, and multidisciplinary coordination are essential for guiding diagnosis and management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.